Zantac Lawsuit Dec 2025 Update, Delaware Supreme Court Crushes 75,000 Cases—What Cancer Victims Must Know Now
The Zantac lawsuit suffered a devastating blow in July 2025 when the Delaware Supreme Court unanimously ruled that plaintiffs in nearly 75,000 pending cases cannot rely on expert testimony linking ranitidine to cancer unless it meets stringent scientific reliability standards. This mirrored the federal court’s 2022 dismissal and followed GSK’s October 2024 settlement of 80,000…
